123 related articles for article (PubMed ID: 22169285)
21. Quantification of VEGF isoforms and VEGFR transcripts by qRT-PCR and their significance in acute myeloid leukemia.
Mourah S; Porcher R; Lescaille G; Rousselot P; Podgorniak MP; Labarchède G; Naimi B; Medioni J; Dombret H; Calvo F
Int J Biol Markers; 2009; 24(1):22-31. PubMed ID: 19404919
[TBL] [Abstract][Full Text] [Related]
22. Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment.
Battula VL; Chen Y; Cabreira Mda G; Ruvolo V; Wang Z; Ma W; Konoplev S; Shpall E; Lyons K; Strunk D; Bueso-Ramos C; Davis RE; Konopleva M; Andreeff M
Blood; 2013 Jul; 122(3):357-66. PubMed ID: 23741006
[TBL] [Abstract][Full Text] [Related]
23. Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas.
Xie D; Yin D; Wang HJ; Liu GT; Elashoff R; Black K; Koeffler HP
Clin Cancer Res; 2004 Mar; 10(6):2072-81. PubMed ID: 15041728
[TBL] [Abstract][Full Text] [Related]
24. [Dynamic analysis of expression of VEGF and its receptor-2 in mouse model with acute myeloid leukemia].
Chen RL; Chen MZ; Yie QY; Tian C; Wang H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):852-6. PubMed ID: 19698215
[TBL] [Abstract][Full Text] [Related]
25. Inverse expression of cystein-rich 61 (Cyr61/CCN1) and connective tissue growth factor (CTGF/CCN2) in borderline tumors and carcinomas of the ovary.
Bartel F; Balschun K; Gradhand E; Strauss HG; Dittmer J; Hauptmann S
Int J Gynecol Pathol; 2012 Sep; 31(5):405-15. PubMed ID: 22833079
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
Nishida N; Yano H; Komai K; Nishida T; Kamura T; Kojiro M
Cancer; 2004 Sep; 101(6):1364-74. PubMed ID: 15368324
[TBL] [Abstract][Full Text] [Related]
27. RASSF1A-Hippo pathway link in patients with urothelial carcinoma of bladder: plausible therapeutic target.
Khandelwal M; Anand V; Appunni S; Seth A; Singh P; Mathur S; Sharma A
Mol Cell Biochem; 2020 Jan; 464(1-2):51-63. PubMed ID: 31754973
[TBL] [Abstract][Full Text] [Related]
28. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
Wierzbowska A; Robak T; Wrzesień-Kuś A; Krawczyńska A; Lech-Marańda E; Urbańska-Ryś H
Eur Cytokine Netw; 2003; 14(3):149-53. PubMed ID: 14656688
[TBL] [Abstract][Full Text] [Related]
29. Bacteria induce CTGF and CYR61 expression in epithelial cells in a lysophosphatidic acid receptor-dependent manner.
Wiedmaier N; Müller S; Köberle M; Manncke B; Krejci J; Autenrieth IB; Bohn E
Int J Med Microbiol; 2008 Apr; 298(3-4):231-43. PubMed ID: 17765657
[TBL] [Abstract][Full Text] [Related]
30. Elevated Expression of VEGF-C and Its Receptors, VEGFR-2 and VEGFR-3, in Patients with Mesial Temporal Lobe Epilepsy.
Sun FJ; Wei YJ; Li S; Guo W; Chen X; Liu SY; He JJ; Yin Q; Yang H; Zhang CQ
J Mol Neurosci; 2016 Jun; 59(2):241-50. PubMed ID: 26798047
[TBL] [Abstract][Full Text] [Related]
31. [Expression and clinical significance of vascular endothelial growth factor and its receptors in multiple myeloma].
Liu JR; Luo SK; Li J; Su C
Ai Zheng; 2007 Jun; 26(6):652-6. PubMed ID: 17562275
[TBL] [Abstract][Full Text] [Related]
32. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
33. Correlation of Cyr61 and CTGF in placentas from the late pre-eclamptic pregnancy.
Chen X; Liu Y; Xu X; Chen H
J Perinat Med; 2012 Feb; 40(2):199-200. PubMed ID: 22905356
[TBL] [Abstract][Full Text] [Related]
34. [Lrp16 gene expression in leukemia cell lines and bone marrow cells of leukemia patients and its clinical implication].
Yang B; Chi XH; Lu XC; Han WD; Yu L; Lou FD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):857-60. PubMed ID: 19698216
[TBL] [Abstract][Full Text] [Related]
35. Expression of VEGF-C/VEGFR-3 in human laryngeal squamous cell carcinomas and its significance for lymphatic metastasis.
Wang Z; Chen Y; Li X; Xu L; Ma W; Chang L; Ju F
Asian Pac J Cancer Prev; 2012; 13(1):27-31. PubMed ID: 22502683
[TBL] [Abstract][Full Text] [Related]
36. Correlation between lymph node metastasis and the expression of VEGF-C, VEGF-D and VEGFR-3 in T1 lung adenocarcinoma.
Maekawa S; Iwasaki A; Shirakusa T; Enatsu S; Kawakami T; Kuroki M; Kuroki M
Anticancer Res; 2007; 27(6A):3735-41. PubMed ID: 17970036
[TBL] [Abstract][Full Text] [Related]
37. Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia.
Hou HA; Chou WC; Lin LI; Tang JL; Tseng MH; Huang CF; Yao M; Chen CY; Tsay W; Tien HF
Leuk Res; 2008 Jun; 32(6):904-12. PubMed ID: 17904634
[TBL] [Abstract][Full Text] [Related]
38. [The relationship between expression of the vascular endothelial growth factor and acute leukemia subtype].
Ye XJ; Lin MF
Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):363-6. PubMed ID: 16185486
[TBL] [Abstract][Full Text] [Related]
39. Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukaemia and myelodysplastic syndrome.
Verstovsek S; Estey E; Manshouri T; Giles FJ; Cortes J; Beran M; Rogers A; Keating M; Kantarjian H; Albitar M
Br J Haematol; 2002 Jul; 118(1):151-6. PubMed ID: 12100142
[TBL] [Abstract][Full Text] [Related]
40. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
